The Efficacy of Factor VIIa in Emergency Department Patients With Warfarin Use and Traumatic Intracranial Hemorrhage

被引:36
|
作者
Nishijima, Daniel K. [1 ]
Dager, William E. [2 ]
Schrot, Rudolph J. [3 ]
Holmes, James F. [1 ]
机构
[1] UC Davis, Sch Med, Dept Emergency Med, Davis, CA 95616 USA
[2] UC Davis, Sch Med, Dept Pharm, Davis, CA USA
[3] UC Davis, Sch Med, Dept Neurosurg, Davis, CA USA
关键词
factor VII; traumatic intracranial hemorrhage; warfarin; ACTIVATED FACTOR-VII; RECOMBINANT-FACTOR-VIIA; ACUTE INTRACEREBRAL HEMORRHAGE; INJURY SEVERITY SCORE; BRAIN-INJURY; DOUBLE-BLIND; ANTICOAGULANT-THERAPY; CLINICAL-TRIAL; HEAD-INJURIES; REVERSAL;
D O I
10.1111/j.1553-2712.2010.00666.x
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: The objective was to compare outcomes in emergency department (ED) patients with preinjury warfarin use and traumatic intracranial hemorrhage (tICH) who did and did not receive recombinant activated factor VIIa (rFVIIa) for international normalized ratio (INR) reversal. Methods: This was a retrospective before-and-after study conducted at a Level 1 trauma center, with data from 1999 to 2009. Eligible patients had preinjury warfarin use and tICH on cranial computed tomography (CT) scan. Patients before (standard cohort) and after (rFVIIa cohort) implementation of a protocol for administering 1.2 mg of rFVIIa in the ED were reviewed. Glasgow Coma Scale (GCS) score, Revised Trauma Score (RTS), Injury Severity Score (ISS), INR, and Marshall score were collected. Outcome measures included mortality, thromboembolic complications, and INR normalization. Results: Forty patients (median age = 80.5 years, interquartile range [IQR] = 63.5-85) were included (20 in each cohort). Age, GCS score, ISS, RTS, initial INR, and Marshall score were similar (p > 0.05) between the two cohorts. Survival was identical between cohorts (13 of 20, or 65.0%, 95% confidence interval [CI] = 40.8% to 84.6%). There were no differences in rate of thromboembolic complications in the standard cohort (1 of 20, 5.0%, 95% CI = 0.1% to 24.9%) than the rFVIIa cohort (4 of 20, 20.0%, 95% CI = 5.7% to 43.7%; p = 0.34). Time to normal INR was earlier in the rFVIIa cohort (mean = 4.8 hours, 95% CI = 3.0 to 6.7 hours) than in the standard cohort (mean = 17.5 hours, 95% CI = 12.5 to 22.6; p < 0.001). Conclusions: In patients with preinjury warfarin and tICH, use of rFVIIa was associated with a decreased time to normal INR. However, no difference in mortality was identified. Use of rFVIIa in patients on warfarin and tICH requires further study to demonstrate important patient-oriented outcomes. ACADEMIC EMERGENCY MEDICINE 2010; 17:244-251 (C) 2010 by the Society for Academic Emergency Medicine.
引用
收藏
页码:244 / 251
页数:8
相关论文
共 50 条
  • [21] Alcohol use is associated with intracranial hemorrhage in older emergency department head trauma patients
    Zirulnik, Alexander
    Liu, Shan
    Wells, Mike
    Alter, Scott M.
    Engstrom, Gabriella
    Solano, Joshua J.
    Clayton, Lisa M.
    Reiter, Mark
    Hughes, Patrick G.
    Goldstein, Lara
    Shih, Richard D.
    JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2024, 5 (04)
  • [22] Factor VIIa (recombinant) for acute traumatic hemorrhage
    Patanwala, Asad E.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (17) : 1616 - 1623
  • [23] THROMBOEMBOLIC RISKS OF ACTIVATED FACTOR VIIA USE IN WARFARIN-ASSOCIATED INTRACEREBRAL HEMORRHAGE
    Chou, Sherry
    Cai, Xuemei
    Konigsberg, Rachael
    Bresette, Linda
    Henderson, Galen
    Sorond, Farzaneh
    Ropper, Allan
    Feske, Steven
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A422 - A422
  • [24] Use of factor IX complex in warfarin-related intracranial hemorrhage
    Boulis, NM
    Bobek, MP
    Schmaier, A
    Hoff, JT
    NEUROSURGERY, 1999, 45 (05) : 1113 - 1118
  • [25] Recombinant factor VIIa for warfarin-associated intracranial bleeding
    Ityas, Can
    Beyer, Ginine M.
    Dutton, Richard P.
    Scatea, Thomas M.
    Hess, John R.
    JOURNAL OF CLINICAL ANESTHESIA, 2008, 20 (04) : 276 - 279
  • [26] The use of recombinant factor VIIa in warfarin patients with traumatic brain injury: a retrospective case-control study
    DeLoughery, Emma P.
    Lenfesty, Barbara
    DeLoughery, Thomas G.
    BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (03) : 317 - 320
  • [27] Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality
    Ivascu, FA
    Howells, GA
    Junn, FS
    Bair, HA
    Bendick, PJ
    Janczyk, RJ
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (05): : 1131 - 1137
  • [28] Author response: Traumatic and spontaneous intracranial hemorrhage in atrial fibrillation patients on warfarin
    Lehtola, Heidi
    Palomaki, Antti
    Mustonen, Pirjo
    Hartikainen, Paivi
    Airaksinen, Juhani
    Hartikainen, Juha
    NEUROLOGY-CLINICAL PRACTICE, 2019, 9 (01) : 3 - 4
  • [29] Critical Emergency Department Interventions and Clinical Deterioration in Children With Nonsevere Traumatic Intracranial Hemorrhage
    Chaudhari, Pradip P.
    Durham, Susan
    Bachur, Richard G.
    Goodhue, Catherine J.
    Levitt, Danielle
    Semple-Hess, Janet
    Gao, Leland
    Pineda, Jose
    Khemani, Robinder G.
    PEDIATRIC EMERGENCY CARE, 2024, 40 (06) : e68 - e75
  • [30] Coagulopathic patients with traumatic intracranial bleeding: Defining the role of recombinant factor VIIa
    Bartal, Carmi
    Freedman, John
    Bowman, Kim
    Cusimano, Michael
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2007, 63 (04): : 725 - 732